Aqr Capital Management LLC Athersys, Inc Transaction History

Aqr Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.41 - $1.94 $68,162 - $93,783	-48,342 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.61 - $2.77 $46,693 - $80,335	-29,002 Reduced 37.5%	48,342 $87,000
Q4 2020 Feb 16, 2021	SELL	$1.55 - $2.24 $24,640 - $35,609	-15,897 Reduced 17.05%	77,344 $135,000
Q3 2020 Nov 16, 2020	BUY	$1.91 - $3.08 $66,557 - $107,328	34,847 Added 59.68%	93,241 $182,000
Q2 2020 Aug 17, 2020	BUY	$1.97 - $3.98 $87,493 - $176,763	44,413 Added 317.67%	58,394 $161,000
Q2 2019 Aug 14, 2019	SELL	$1.39 - $2.03 $75,392 - $110,105	-54,239 Reduced 79.51%	13,981 $23,000
Q4 2018 Feb 14, 2019	SELL	$1.41 - $2.16 $56,708 - $86,873	-40,219 Reduced 37.09%	68,220 $98,000
Q2 2018 Aug 14, 2018	BUY	$1.76 - $2.79 $190,852 - $302,544	108,439 New	108,439 $214,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.